Meningococcal conjugate vaccine is used to prevent infection caused by meningococcal bacteria. Learn More
Time frame: 14 months
Age requirements: ≥ 42 to ≤ 89 days on the day of the first study visit
Compensation: Group 1a up to $720
Group 1b and 2b up to $840
Group 2a up to $960
Key Inclusion Criteria:
At screening visit, additional criteria will be reviewed to determine eligibility for the study. Qualified participants will receive study medication, medical care and compensation for the time and travel of each completed study visit.
COMPENSATION AVAILABLE PER CLINICAL STUDY
Thank you for your interest in our studies. Please use the following form to begin your enrollment process in a clinical trial or to join our database of opted-in patients. You will receive notification via email and/or regular mail about new clinical trial opportunities.
Fields marked with an asterisk (*) are required.